Synthesis, biological evaluation and mechanism study of 2-benzoyl-quinazolinone derivative as ferroptosis inhibitor for the treatment of Parkinson's disease

Key Points

• Ferroptosis inhibition shows promise in improving conditions associated with Parkinson's disease, indicating potential therapeutic applications.
• The biological evaluation of the 2-benzoyl-quinazolinone derivative reveals significant protective effects against neurodegeneration.
• Mechanism studies indicate that the compound operates through specific pathways crucial for neuron survival.
• Ferroptosis inhibition may provide a novel approach to manage Parkinson's disease, indicating a need for further clinical exploration.